Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide
2. 3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)-propionamide
3. S-4 Cpd
1. 401900-40-1
2. Gtx-007
3. (2s)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
4. Gtx007
5. S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethyl-phenyl)-propionamide
6. 7ut2hah49h
7. Chembl125236
8. Propanamide, 3-(4-(acetylamino)phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-(trifluoromethyl)phenyl)-, (2s)-
9. Andarine (gtx-007)
10. (2s)-3-(4-acetamido-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethyl-phenyl)-propionamide
11. (s)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-(trifluoromethyl)phenyl)propanamide
12. S-4
13. S-4 Cpd
14. Andarine;s4
15. Unii-7ut2hah49h
16. (s)-andarine
17. H_166_andarine_s4
18. Andarine - Gtx-007
19. Sarm S-4
20. Mls006010738
21. Gtx 007
22. Nonsteroidal Ar Ligand, S-6
23. Gtpl7849
24. Schembl2689756
25. Bdbm18665
26. Chebi:94760
27. Dtxsid40193187
28. Ex-a724
29. 3b68
30. Bcpp000400
31. Hms3654m08
32. Amy38109
33. Bcp01832
34. Zinc3991693
35. Mfcd09027386
36. S1140
37. Akos005145785
38. Akos015841082
39. Bmc185567 S-4
40. Bcp9000302
41. Ccg-264833
42. Cs-0160
43. Db07423
44. Ncgc00263150-01
45. Ncgc00263150-02
46. Ncgc00263150-04
47. Ac-26920
48. As-19581
49. Hy-12023
50. N-[4-nitro-3-(trifluoromethyl)phenyl]-(2s)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methylpropanamide
51. Smr004701697
52. Sw219160-1
53. 900n401
54. J-523346
55. Q4753617
56. Brd-k82164249-001-02-7
57. (2s)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-n-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
58. (s)-3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide
59. (s)-3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide, Analytical Standard
60. 3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)propionamide
61. 3-(4-acetylaminophenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethylphenyl)-propionamide
62. B68
63. N-[4-ntro-3-(trfluoromethyl)phenyl]-(2s)-3-[4-(acetylamno)phenoxy]-2-hydroxy-2-methylpropanamde
64. Propanamide, 3-?[4-?(acetylamino)?phenoxy]?-?2-?hydroxy-?2-?methyl-?n-?[4-?nitro-?3-?(trifluoromethyl)?phenyl]?-?, (2s)?-
Molecular Weight | 441.4 g/mol |
---|---|
Molecular Formula | C19H18F3N3O6 |
XLogP3 | 2.2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 6 |
Exact Mass | 441.11476979 g/mol |
Monoisotopic Mass | 441.11476979 g/mol |
Topological Polar Surface Area | 134 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 663 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?